Literature DB >> 9142935

Nitric oxide attenuates lung endothelial injury caused by sublethal hyperoxia in rats.

M C McElroy1, J P Wiener-Kronish, H Miyazaki, T Sawa, K Modelska, L G Dobbs, J F Pittet.   

Abstract

Inhaled nitric oxide (NO) has been shown to prevent oxidant-induced lung injury in isolated-perfused lung models, whereas NO-derived oxidants may contribute to acute lung injury secondary to hyperoxia. Whether inhaled NO improves or contributes to oxidant-mediated lung injury may depend on the timing of NO administration or how lung injury is assessed. The objective of these studies was to determine whether inhaled NO (20 ppm) was protective or harmful to the different lung barriers when it was administered with 95% O2 for 60 h in Sprague-Dawley rats by measuring fluid transport and permeability to protein across the lung endothelium and the alveolar epithelium. Inhaled NO significantly attenuated the O2-mediated lung endothelial injury and abolished the increase in the bronchoalveolar lavage fluid content of rTI40, a specific and sensitive marker of alveolar epithelial type I cell injury, that occurs secondary to hyperoxia. In conclusion, inhaled NO administered with high concentrations of O2 may protect the lung endothelium and the alveolar epithelium against O2-mediated injury.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9142935     DOI: 10.1152/ajplung.1997.272.4.L631

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  15 in total

Review 1.  Intracellular signalling involved in modulating human endothelial barrier function.

Authors:  Victor W M van Hinsbergh; Geerten P van Nieuw Amerongen
Journal:  J Anat       Date:  2002-06       Impact factor: 2.610

2.  HTII-280, a biomarker specific to the apical plasma membrane of human lung alveolar type II cells.

Authors:  Robert F Gonzalez; Lennell Allen; Linda Gonzales; Philip L Ballard; Leland G Dobbs
Journal:  J Histochem Cytochem       Date:  2010-06-21       Impact factor: 2.479

3.  Inhaled nitric oxide increases endothelial permeability in Pseudomonas aeruginosa pneumonia.

Authors:  Florence Ader; Rozenn Le Berre; Steve Lancel; Karine Faure; Nathalie B Viget; Emmanuel Nowak; Rémi Nevière; Benoit P Guery
Journal:  Intensive Care Med       Date:  2007-01-12       Impact factor: 17.440

Review 4.  Aberrant signaling pathways of the lung mesenchyme and their contributions to the pathogenesis of bronchopulmonary dysplasia.

Authors:  Shawn K Ahlfeld; Simon J Conway
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2011-11-28

5.  Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury.

Authors:  Tokujiro Uchida; Madoka Shirasawa; Lorraine B Ware; Katsuo Kojima; Yutaka Hata; Koshi Makita; Gabe Mednick; Zachary A Matthay; Michael A Matthay
Journal:  Am J Respir Crit Care Med       Date:  2006-02-02       Impact factor: 21.405

6.  High-dose nitric oxide inhalation increases lung injury after gastric aspiration.

Authors:  N D Nader; P R Knight; I Bobela; B A Davidson; K J Johnson; F Morin
Journal:  Anesthesiology       Date:  1999-09       Impact factor: 7.892

7.  Smoldering and flaming biomass wood smoke inhibit respiratory responses in mice.

Authors:  Marie McGee Hargrove; Yong Ho Kim; Charly King; Charles E Wood; M Ian Gilmour; Janice A Dye; Stephen H Gavett
Journal:  Inhal Toxicol       Date:  2019-08-20       Impact factor: 2.724

8.  Stimulators of soluble guanylyl cyclase: future clinical indications.

Authors:  Bobby D Nossaman; Philip J Kadowitz
Journal:  Ochsner J       Date:  2013

9.  Rat alveolar type I cells proliferate, express OCT-4, and exhibit phenotypic plasticity in vitro.

Authors:  Robert F Gonzalez; Lennell Allen; Leland G Dobbs
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-08-28       Impact factor: 5.464

10.  Apoptosis inhibition in P. aeruginosa-induced lung injury influences lung fluid balance.

Authors:  Rozenn Le Berre; Karine Faure; Harold Fauvel; Nathalie B Viget; Florence Ader; Thierry Prangère; Anne Marie Thomas; Xavier Leroy; Jean-François Pittet; Philippe Marchetti; Benoit P Guery
Journal:  Intensive Care Med       Date:  2004-02-26       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.